6.140
−1,13%
2026-10-15
Fundamental Analysis
81 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +113.6% | +163.3% | 3 / 3 | +23.9% | +0.38 pp | +11.35 pp | +5.7% | 0.68 | 6.92 | 158 | +23,9% | 1,8 | +113,6% | 6.92 | 6.10 | +13,4% |
| Pts | 12 | 12 | 12 | 12 | 8 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 6.140 (close price on 2026-10-15)EPS (TTM): 887,5
Financial charts
1.Revenue & growth
VND bn158Q2/26
1.Revenue & growth
VND bn158Q2/26
2.Profit & growth
VND bn1,78Q2/26
3.Profit mix (Penman)
VND bn30,9Q2/26
4.Margins & cost structure
%27.8%Q2/26
5.Returns & cash cycle
% · days3.4%Q2/26
6.Earnings quality & cash
VND bn-17,8Q2/26
7.Asset structure
VND bn847Q2/26
8.Funding & debt health
VND bn · times847Q2/26
9.Revenue backlog
VND bn8,66Q2/26
10.Valuation
times · %7,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %62Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26